Preparation, characterization, and toxicity evaluation of microemulsion formulation containing prunetin for potential oral applications
Phytochemicals as therapeutic alternatives can have a fundamental impact on the various stages of inflammation and its resolution. Prunetin is a naturally occurring isoflavone and has been claimed to have numerous therapeutic potentials. The objective of this study is preparation, characterization, and toxicity evaluation of microemulsion formulation containing prunetin (PMF) for potential oral applications. With this research, it was targeted to emphasize the way of improving the therapeutic efficacy of natural biomolecules with a nontoxic and effective formulation. In the study, the pseudo-ternary phase diagram was developed and PMF was characterized by conductivity, droplet size, viscosity and pH. Effects against to cytokines (IL-1β and IL-6) and TNF-α levels of the PMF were determined by ELISA technique. Genotoxicity and acute oral toxicity tests were carried out according to OECD guidelines. The results showed that PMF is a colloid system that reduced proinflammatory cytokine levels in LPS-induced macrophage cells compared to the control group. PMF demonstrated no mutagenic activity against TA98, TA100, TA1535, and TA1537 Salmonella strains. The in vivo oral acute toxicity test results indicated that PMF did not show mortality or significant side effects even at 2000 mg/kg bw. This study represents PMF showed a good safety profile in animal study. It is thought that this formulation may have anti-inflammatory potential with further in vivo testing.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Drug and chemical toxicology - 47(2024), 2 vom: 15. Feb., Seite 235-242 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Köksal Karayıldırım, Çinel [VerfasserIn] |
---|
Links: |
---|
Themen: |
1TG4H5H11J |
---|
Anmerkungen: |
Date Completed 09.02.2024 Date Revised 09.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/01480545.2023.2282373 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364818557 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364818557 | ||
003 | DE-627 | ||
005 | 20240209231956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/01480545.2023.2282373 |2 doi | |
028 | 5 | 2 | |a pubmed24n1285.xml |
035 | |a (DE-627)NLM364818557 | ||
035 | |a (NLM)37990576 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Köksal Karayıldırım, Çinel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preparation, characterization, and toxicity evaluation of microemulsion formulation containing prunetin for potential oral applications |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.02.2024 | ||
500 | |a Date Revised 09.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Phytochemicals as therapeutic alternatives can have a fundamental impact on the various stages of inflammation and its resolution. Prunetin is a naturally occurring isoflavone and has been claimed to have numerous therapeutic potentials. The objective of this study is preparation, characterization, and toxicity evaluation of microemulsion formulation containing prunetin (PMF) for potential oral applications. With this research, it was targeted to emphasize the way of improving the therapeutic efficacy of natural biomolecules with a nontoxic and effective formulation. In the study, the pseudo-ternary phase diagram was developed and PMF was characterized by conductivity, droplet size, viscosity and pH. Effects against to cytokines (IL-1β and IL-6) and TNF-α levels of the PMF were determined by ELISA technique. Genotoxicity and acute oral toxicity tests were carried out according to OECD guidelines. The results showed that PMF is a colloid system that reduced proinflammatory cytokine levels in LPS-induced macrophage cells compared to the control group. PMF demonstrated no mutagenic activity against TA98, TA100, TA1535, and TA1537 Salmonella strains. The in vivo oral acute toxicity test results indicated that PMF did not show mortality or significant side effects even at 2000 mg/kg bw. This study represents PMF showed a good safety profile in animal study. It is thought that this formulation may have anti-inflammatory potential with further in vivo testing | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Isoflavones | |
650 | 4 | |a acute oral toxicity | |
650 | 4 | |a cytokines | |
650 | 4 | |a microemulsion | |
650 | 4 | |a prunetin | |
650 | 7 | |a prunetin |2 NLM | |
650 | 7 | |a 1TG4H5H11J |2 NLM | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Isoflavones |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Mutagens |2 NLM | |
700 | 1 | |a Üstündağ Okur, Neslihan |e verfasserin |4 aut | |
700 | 1 | |a Okur, Mehmet Evren |e verfasserin |4 aut | |
700 | 1 | |a Caglar, Emre Şefik |e verfasserin |4 aut | |
700 | 1 | |a Nalbantsoy, Ayşe |e verfasserin |4 aut | |
700 | 1 | |a Alsakını, Karar Ali Mohammed Hasan |e verfasserin |4 aut | |
700 | 1 | |a Karabay Yavasoglu, Nefise Ülkü |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug and chemical toxicology |d 1984 |g 47(2024), 2 vom: 15. Feb., Seite 235-242 |w (DE-627)NLM000913685 |x 1525-6014 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2024 |g number:2 |g day:15 |g month:02 |g pages:235-242 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/01480545.2023.2282373 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2024 |e 2 |b 15 |c 02 |h 235-242 |